Brief: Iterum Begins Two Phase 3 Trials For Sulopenem

Arix Bioscience

18/09/2018 14:04

Sept 18 (Reuters) - Arix Bioscience PLC  ARIX.L :
    * UPDATE ON ITERUM THERAPEUTICS PHASE 3 TRIALS
    * ITERUM INITIATED REMAINING TWO OF THREE PLANNED PHASE 3
PIVOTAL
TRIALS OF IV AND ORAL SULOPENEM
    * TOP-LINE RESULTS FOR SURE 2 AND SURE 3 EXPECTED IN SECOND
HALF
OF 2019
    * NDA SUBMISSIONS AFTER SURE 2 AND SURE 3 TRIALS ANTICIPATED
BY
END OF 2019

Source text for Eikon:  ID:nPRrI43A0a 
Further company coverage:  ARIX.L 

 ((Reuters.Briefs@thomsonreuters.com;))